NCT05508412View on ClinicalTrials.gov

Cancer Patient Empowerment Program: Phase 2 Feasibility Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

December 6, 2022

Primary Completion Date

February 1, 2025

Study Completion Date

March 15, 2025

Conditions
Cancer
Interventions
BEHAVIORAL

CancerPEP

CancerPEP

Trial Locations (1)

B3H 2Y9

QEII Health Sciences Centre, Halifax

All Listed Sponsors
collaborator

Dalhousie University

OTHER

lead

Nova Scotia Health Authority

OTHER